| Literature DB >> 16968156 |
Jens M Kelm1, Valentin Djonov, Lars M Ittner, David Fluri, Walter Born, Simon P Hoerstrup, Martin Fussenegger.
Abstract
Tissue engineering strategies are gathering clinical momentum in regenerative medicine and are expected to provide excellent opportunities for therapy for difficult-to-treat human pathologies. Being aware of the requirement to produce larger artificial tissue implants for clinical applications, we used microtissues, produced using gravity-enforced self-assembly of monodispersed primary cells, as minimal tissue units to generate scaffold-free vascularized artificial macrotissues in custom-shaped agarose molds. Mouse myoblast, pig and human articular-derived chondrocytes, and human myofibroblast (HMF)-composed microtissues (microm3 scale) were amalgamated to form coherent macrotissue patches (mm3 scale) of a desired shape. Macrotissues, assembled from the human umbilical vein endothelial cell (HUVEC)-coated HMF microtissues, developed a vascular system, which functionally connected to the chicken embryo's vasculature after implantation. The design of scaffold-free vascularized macrotissues is a first step toward the scale-up and production of artificial tissue implants for future tissue engineering initiatives.Entities:
Mesh:
Year: 2006 PMID: 16968156 DOI: 10.1089/ten.2006.12.2151
Source DB: PubMed Journal: Tissue Eng ISSN: 1076-3279